Dr. Gregory J. Shypula, M.D.

Clinical Trials

• Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma

Media Releases

Get to know Hematologist-Oncologist Dr. Gregory J. Shypula, who serves patients in Avenel, New Jersey.

A skilled hematologist-oncologist, Dr. Shypula sees patients at his private practice – Gregory J. Shypula, M.D., P.A. – located in Avenel, New Jersey. He has over two decades of experience offering exceptional care and treatment for patients with cancers and blood disorders. 

Having established his private practice in 1992, Dr. Shypula and his staff are committed to providing state-of-the-art medical care in a community setting. They provide comprehensive screening, diagnosis, and treatment of various blood disorders and cancers in a compassionate and supportive environment.

Among his other titles, Dr. Shypula is the Director of the Division of Hematology/Oncology at the Raritan Bay Medical Center; a position he has held since 1996. He is also a Clinical Assistant Professor in the Department of Medicine at the Robert Wood Johnson Medical School (UMDNJ); an attending physician at Raritan Bay Medical Center, John F. Kennedy Medical Center, Rahway Hospital, and Robert Wood Johnson University Hospital; and remains affiliated with The Cancer Institute of New Jersey. 

With a broad educational background, Dr. Shypula graduated with his medical degree from Wroclaw Medical University in Poland in 1981. He then relocated to the United States, performing his internship and residency in internal medicine at Raritan Bay Medical Center in Perth Amboy, New Jersey. He then went on to complete his fellowship in the Division of Hematology and Oncology at St. Luke’s /Roosevelt Hospital in New York City. 

Subsequent to his education, the doctor attained board certification in hematology, medical oncology, and internal medicine through the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

On a professional level, Dr. Shypula is an active member of the American Society of Clinical Oncology.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of cancer, malignant blood diseases such as leukemia, lymphoma, and multiple myeloma, and blood disorders such as iron-deficiency anemia, clotting abnormalities, hemophilia, and sickle-cell disease.

Throughout his line of work, Dr. Shypula has authored several articles that have been published in scientific, peer-reviewed journals. 

Among his various accolades include: Physician of the Year 2003 – The National Republican Congressional Committees Physicians Advisory Board; Distinguished Fellow of the American Academy of Oncology Award (2008); Top Doctors for Women’s Health – Castle Connolly Ltd., Inside Jersey (February 2010 & February 2011); New Jersey Best Doctors 2010 – Castle Connolly Ltd; America’s Top Oncologists 2009 – Consumers Research Council of America; Distinguished Physician of the Year 2006 – Raritan Bay Medical Center; America’s Top Physicians 2004 – 2005 (Hematology/Oncology) – Consumers Research Council of America; Top Doctors in the New York Metro Area 2001 & 2003 – Castle Connolly Ltd.; Honoree – American Cancer Society – Second Annual Look Good Feel Better Gala 2000; and Strathmore’s Who’s Who Lifetime Member.

Recommended Articles

• The Effect of Sunshine on Lymphoma

  Having a lack of enough vitamin D can drastically effect one's ability to fight many cancers, including lymphoma. So, researchers inevitably wondered whether the addition of Vitamin D to preexisting therapies would prolong patients' lives. The Wilmot Cancer Institute received a $3 million grant for...

• 'Robocop' Stem Cells Developed to Fight Cancer

  Cancer is the second-leading cause of death in the United States, although due to several advancements in cancer screening and treatment, survival rates have begun to improve.A new cancer therapyResearchers at the University of Minnesota and Mayo Clinic have developed a new type of cancer therapy...

• Microsoft Co-Founder Paul Allen Beats Lymphoma Twice

  Beating any type of cancer is a major feat in itself, but billionaire and Microsoft co-founder Paul Allen has defeated lymphoma not once, but twice.Paul's storyNeedless to say, being the co-founder of Microsoft is a pretty big deal. As an American digital pioneer, Paul has been on top of the world....

• Can Multiple Myeloma be Asymptomatic?

  Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...

• How This Survivor Star Beat Hodgkin Lymphoma—Twice

  Ethan Zohn is a survivor in many ways. In 2002, he outlasted 15 fiercely strong competitors on the popular TV show, Survivor: Africa. His strength, wit, athleticism, and perseverance won him a million-dollar prize after he defeated these opponents. However, his victory was short-lived. Little did he...

• Multiple Myeloma: What is Autotransplantation?

  During a stem cell transplantation or autotransplantation, the patient receives high chemotherapy dosage which is sometimes done to the entire body to get rid of the cells that are in the bone marrow (including the myeloma cells). Afterwards, the patient receives new stem cells to form...